I am/have/had
I am looking for
Advanced Filters
Found 1 clinical trials
Acalabrutinib Lenalidomide and Rituximab for the Treatment of CD20 Positive Stage III-IV Grade 1-3a Follicular Lymphoma
This phase II trial studies how well acalabrutinib, lenalidomide, and rituximab work in treating patients with CD20 positive stage III-IV, grade 1-3a follicular lymphoma. Acalabrutinib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth.
platelet count
grade 3a follicular lymphoma
rituximab
tumor cells
beta human chorionic gonadotropin
- 0 views
- 19 Feb, 2024
- 1 location